Koers CannaVEST Corp OTC Bulletin Board
Aandelen
US1376531018
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
14/05 | CV Sciences zoekt mogelijkheden voor fusies en overnames | CI |
14/05 | Transcript : CV Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Omzet 2022 | 16,2 mln. 14,94 mln. | Omzet 2023 | 16 mln. 14,76 mln. | Marktkapitalisatie | 5,47 mln. 5,04 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -9 mln. -8,3 mln. | Nettowinst (verlies) 2023 | 3 mln. 2,77 mln. | EV/omzet 2022 | 0,36 x |
Nettoschuld 2022 | 917K 846K | Nettoliquiditeiten 2023 | 875K 807K | EV/omzet 2023 | 0,29 x |
K/w-verhouding 2022 |
-0,44
x | K/w-verhouding 2023 |
1,77
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,98% |
Recentste transcriptie over CannaVEST Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16-06-14 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 26-12-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16-06-14 |
Jamie Corroon
BRD | Director/Board Member | 54 | 21-07-22 |
William McCorkle
BRD | Director/Board Member | 56 | 21-10-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |
- Beurs
- Aandelen
- Koers CVSI
- Koers